Cegedim: 6% sales growth by 2022
"This moderate growth in the final quarter stems essentially from December 2022, which saw sales increase by 0.4% compared with December 2021, the lowest monthly growth rate of the year", the company states.
The launch of Cegedim Santé's development plan and lower sales in the UK will have a negative impact on operating income recurring in 2022. Cegedim anticipates sales growth in 2023 in the 6% to 9% range.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Go to the original article.
Contact us to request a correction